Pharmaceutical Companies Recent News
Another Short Thesis On Mallinckrodt Just Surfaced
Exclusive: Recro Pharma CEO Talks Meloxicam, Alleviating Investor Concerns
Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals
This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders
Even After Dipping Under $21, Morgan Stanley Says Myriad Genetics Is Not Cheap
Celgene Reports Second-Quarter Results, Highlights 'Outstanding' 2016 Performance
Importance Of Phase III Trials
Importance Of Phase 1 Trials
The FDA Showing Valeant Some Love With Recent Drug Approvals
Carl Icahn's New Stake In Allergan
Eli Lilly Says It Will Launch 20 New Products Through 2023
Here's Why NephroGenex Plunged 40% On Wednesday
Mallinckrodt Reports Better-Than-Expected Q1, Raises Guidance
Massachusetts Attorney General To Gilead Sciences: Cost Of Harvoni & Sovaldi Drugs 'May Constitute An Unfair Trade Practice In Violation Of Massachusetts Law'
5 Specialty Pharma Stocks Nomura Is Picking To Weather The Storm
Getting The Word Out To Cannabis Users: A Chat With BudgetWeed CEO Marlon Fuller